In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug
about
USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cellsCyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma.In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma.Identification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer.Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cells.Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug.Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.Pyrrole and Fused Pyrrole Compounds with Bioactivity against Inflammatory Mediators.Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets
P2860
Q33648632-237F44A2-D498-40B7-B6A5-9FA42628B88EQ36729132-A43D32C2-7E01-493C-86C2-DAA9C739B86FQ37269126-C200976B-3D53-439C-BBD7-D82B98D29C0EQ37427855-591F4241-5D96-4D14-8F78-A4900DE4EEA1Q38734306-59BA0A79-A02B-4393-B3E2-B52A007312D0Q47100541-DDA31B2E-EAA3-4442-80A4-54C3C08B729DQ47158976-3A4D7511-A147-4C41-AE6E-AC043BCEABFFQ49262902-B040FC08-5C0F-46BF-A387-5FB8E3950CE1Q49562067-5EADD4E9-130A-4662-A921-C0367EFBBE64Q51095426-274518BF-6DD1-4BAF-B056-476BF6400F36Q58767948-F099CDAC-638D-4E53-B46D-2A553607CA38
P2860
In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
In Silico Identification and I ...... d a Candidate Anti-Cancer Drug
@ast
In Silico Identification and I ...... d a Candidate Anti-Cancer Drug
@en
In Silico Identification and I ...... d a Candidate Anti-Cancer Drug
@nl
type
label
In Silico Identification and I ...... d a Candidate Anti-Cancer Drug
@ast
In Silico Identification and I ...... d a Candidate Anti-Cancer Drug
@en
In Silico Identification and I ...... d a Candidate Anti-Cancer Drug
@nl
prefLabel
In Silico Identification and I ...... d a Candidate Anti-Cancer Drug
@ast
In Silico Identification and I ...... d a Candidate Anti-Cancer Drug
@en
In Silico Identification and I ...... d a Candidate Anti-Cancer Drug
@nl
P2093
P2860
P1433
P1476
In Silico Identification and I ...... d a Candidate Anti-Cancer Drug
@en
P2093
Hongjian Li
Hsiang-fu Kung
Kwong-Sak Leung
Man-Hon Wong
Marie Chia-mi Lin
Xi-Nan Shi
P2860
P304
P356
10.1371/JOURNAL.PONE.0132072
P407
P577
2015-01-01T00:00:00Z